Nureca (NURECA) | Stock Overview & Key Data
Nureca Performance Comparison
Stock Range
Today's Range
Low: ₹230.20
High: ₹237.30
on August 14, 2025
52 Week Range
Low: ₹203.62
High: ₹447.50
on April 7, 2025
on January 20, 2025
All-Time High: ₹2,315.00 on October 4, 2021
Explore how other Indian stocks compare to their 52-week ranges: View IN Market 52-Week Insights
Key Statistics
Market Cap
INR2.4B
EPS
0.85
P/E Ratio (TTM)
306.06
Forward P/E
N/A
P/B Ratio
1.21
PEG Ratio
-2.08
Div. Yield
N/A
ROE
0.44%
Beta
0.486
Debt to Equity
2.56
Financial Highlights
Profitability
Gross Margin
35.11%
Operating Margin
-3.20%
Profit Margin
0.00%
Returns and Earnings
Return on Assets (TTM)
0.40%
Return on Equity (TTM)
0.44%
EBITDA
INR620.0K
Net Income (TTM)
INR-30.0K
Growth
Revenue (TTM)
Revenue Per Share (TTM)
INR123.57
Quarterly Revenue Growth (YoY)
68.60%
Quarterly Earnings Growth (YoY)
-51.10%
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Nureca NURECA | 2.36B Small-cap | -1.51% | -19.16% | -6.04% | -14.01% | -18.31% | -11.46% | -76.93% | -65.74% |
| Fischer Medical FISCHER | 62.58B Mid-cap | 2.44% | 23.37% | 17.22% | 40.73% | 41.74% | 51.77% | 1,996.22% | 2,217.52% |
| HSIL Limited HSIL | 53.70B Mid-cap | 0.03% | 15.63% | 10.68% | 34.19% | -16.31% | 7.79% | 224.17% | 1,344.97% |
| Universus Photo UNIVPHOTO | 2.85B Small-cap | -4.36% | -12.23% | 7.32% | 27.16% | 19.48% | -33.19% | -51.70% | 10.76% |
| Maestros Electronics METSL | 849.68M Small-cap | -4.61% | 6.34% | -2.01% | -21.96% | -39.47% | 4.21% | 202.40% | 36.70% |
| Opto Circuits OPTOCIRCUI | 541.13M Small-cap | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -76.32% |
Ownership & Short Interest
Insider Ownership
66.12%
Institutional Ownership
0.00%
Shares Short
N/A
Short Ratio
N/A
Short % of Shares Outstanding
N/A
Average 10-Day Volume
14K
Average 90-Day Volume
19K
Nureca Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in Nureca would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is NURECA's 52-week high and low?
- In the last 52 weeks, Nureca reached a high of ₹447.50 (on January 20, 2025) and a low of ₹203.62 (on April 7, 2025).
- What is the market cap and P/E ratio for NURECA?
- Curious about Nureca's size and valuation? Its market capitalization stands at 2.36B. When it comes to valuation, the P/E ratio (trailing twelve months) is 306.06, and the forward P/E (looking ahead) is N/A.
- Does NURECA pay dividends? If so, what's the yield?
- As for dividends, Nureca isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Nureca's main competitors or similar companies to consider before investing?
When looking at Nureca, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Fischer Medical
FISCHER62.58B Healthcare Medical Devices 51.77% 1,996.22% HSIL Limited
HSIL53.70B Healthcare Medical Devices 7.79% 224.17% Universus Photo
UNIVPHOTO2.85B Healthcare Medical Devices -33.19% -51.70% Maestros Electronics
METSL849.68M Healthcare Medical Devices 4.21% 202.40% Opto Circuits
OPTOCIRCUI541.13M Healthcare Medical Devices 0.00% 0.00% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Nureca Ltd.? (e.g., ROE, Debt/Equity)
- To get a sense of Nureca's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 0.44%, the Debt to Equity ratio from the most recent quarter is 2.56, and its Gross Profit Margin stands at 35.11%.
- What is the recent revenue and earnings growth for NURECA?
- Looking at Nureca's growth, its revenue over the trailing twelve months (TTM) was INR1B. Compared to the same quarter last year (YoY), quarterly revenue grew by 68.60%, and quarterly earnings saw a YoY growth of -51.10%.
- How much of NURECA stock is held by insiders and institutions?
- Wondering who owns Nureca stock? Company insiders (like executives and directors) hold about 66.12% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 0.00%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.